TRPV4 and chronic asthma: TRPV4 channels participate in the KCa3.1-regulated proliferation of human bronchial smooth muscle cells in the process of chronic asthma (Yu et al., 2017), indicating that it is a potential therapeutic target for chronic asthma treatment.